Penn Medicine and Children's Hospital of Philadelphia Awarded Breakthrough Prize for Gene Therapy Advancements
Jean Bennett, MD, PhD, and Albert Maguire, MD, from the University of Pennsylvania, along with Katherine High, MD, from the Children's Hospital of Philadelphia, have been awarded the Breakthrough Prize in Life Sciences. This recognition is for their pioneering work in developing the first FDA-approved gene therapy for Leber Congenital Amaurosis (LCA), a form of inherited blindness. Their research has paved the way for over 140 gene therapy trials targeting retinal conditions, impacting millions in the U.S. The Breakthrough Prize, often referred to as the 'Oscars of Science,' acknowledges significant scientific achievements and includes a $3 million award. This accolade highlights the team's perseverance in overcoming scientific challenges to bring sight to individuals who would otherwise face blindness. 
